High-throughput proteomics using antibody microarrays
- 1 October 2004
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 1 (3) , 355-364
- https://doi.org/10.1586/14789450.1.3.355
Abstract
Antibody-based microarrays are a novel technology that hold great promise in proteomics. Microarrays can be printed with thousands of recombinant antibodies carrying the desired specificities, the biologic sample (e.g., an entire proteome) and any specifically bound analytes detected. The microarray patterns that are generated can then be converted into proteomic maps, or molecular fingerprints, revealing the composition of the proteome. Using this tool, global proteome analysis and protein expression profiling will thus provide new opportunities for biomarker discovery, drug target identification and disease diagnostics, as well as providing insights into disease biology. Intense work is currently underway to develop this novel technology platform into the high-throughput proteomic tool required by the research communityKeywords
This publication has 44 references indexed in Scilit:
- Methods and applications of antibody microarrays in cancer researchProteomics, 2003
- Identification of repertoires of surface antigens on leukemias using an antibody microarrayProteomics, 2003
- ProteomicsAnnual Review of Biochemistry, 2003
- Recent Developments in Protein Microarray TechnologyAngewandte Chemie International Edition in English, 2003
- Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkersProteomics, 2003
- Protein chip technologyCurrent Opinion in Chemical Biology, 2002
- Protein microarrays and proteomicsNature Genetics, 2002
- Gene Expression Profiling of Lymphoid MalignanciesAnnual Review of Medicine, 2002
- Proteomic profiling of the cancer microenvironment by antibody arraysProteomics, 2001
- Antibodies in diagnostics – from immunoassays to protein chipsImmunology Today, 2000